
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Nutr</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Nutr</journal-id><journal-title-group><journal-title>European Journal of Nutrition</journal-title></journal-title-group><issn pub-type="ppub">1436-6207</issn><issn pub-type="epub">1436-6215</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27015912</article-id><article-id pub-id-type="pmc">5486642</article-id><article-id pub-id-type="publisher-id">1202</article-id><article-id pub-id-type="doi">10.1007/s00394-016-1202-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Contribution</subject></subj-group></article-categories><title-group><article-title>Vitamin D<sub>3</sub> supplementation using an oral spray solution resolves deficiency but has no effect on VO<sub>2</sub> max in Gaelic footballers: results from a randomised, double-blind, placebo-controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Todd</surname><given-names>Joshua J.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>McSorley</surname><given-names>Emeir M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pourshahidi</surname><given-names>L. Kirsty</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Madigan</surname><given-names>Sharon M.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Laird</surname><given-names>Eamon</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Healy</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Magee</surname><given-names>Pamela J.</given-names></name><address><phone>+44 28 70124360</phone><email>pj.magee@ulster.ac.uk</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000105519715</institution-id><institution-id institution-id-type="GRID">grid.12641.30</institution-id><institution>Northern Ireland Centre for Food and Health, </institution><institution>University of Ulster, </institution></institution-wrap>Coleraine, UK </aff><aff id="Aff2"><label>2</label>Irish Institute of Sport, Sports Campus Ireland, Abbotstown, Dublin 15, UK </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121885934</institution-id><institution-id institution-id-type="GRID">grid.5335.0</institution-id><institution>Institute of Molecular Medicine, </institution><institution>Trinity College, </institution></institution-wrap>Dublin, UK </aff><aff id="Aff4"><label>4</label>Department of Medicine, Trinity Centre for Health Science St. James&#x02019;s Hospital, Dublin, UK </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>3</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>3</month><year>2016</year></pub-date><pub-date pub-type="ppub"><year>2017</year></pub-date><volume>56</volume><issue>4</issue><fpage>1577</fpage><lpage>1587</lpage><history><date date-type="received"><day>19</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>7</day><month>3</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1"> Vitamin D inadequacy is a global health concern in athletes as well as the general population. Whilst the role of vitamin D in skeletal health is well defined, there remains uncertainty over whether vitamin D supplementation has an added benefit beyond bone health.</p></sec><sec><title>Methods</title><p id="Par2">This randomised placebo-controlled trial in healthy male and female Gaelic footballers (<italic>n</italic>&#x000a0;=&#x000a0;42) investigated the effect of vitamin D<sub>3</sub> supplementation [3000&#x000a0;IU (75&#x000a0;&#x000b5;g) daily for 12&#x000a0;weeks, via an oral spray solution] on VO<sub>2</sub> max which was the primary outcome measure. Secondary outcomes included skeletal muscle and lung function.</p></sec><sec><title>Results</title><p id="Par3">Supplementation significantly increased total 25-hydroxyvitamin D concentrations compared to the placebo group (mean&#x000a0;&#x000b1;&#x000a0;SD change from baseline, 36.31&#x000a0;&#x000b1;&#x000a0;32.34 vs. 6.11&#x000a0;&#x000b1;&#x000a0;23.93&#x000a0;nmol/L, respectively; <italic>P</italic>&#x000a0;=&#x000a0;0.006). At baseline, 50 and 22&#x000a0;% of footballers presented with vitamin D insufficiency (31&#x02013;49&#x000a0;nmol/L) and deficiency (&#x0003c;30&#x000a0;nmol/L), respectively. Total 25-hydroxyvitamin D concentration did not significantly correlate with any measure of physical performance. Analysis of covariance (ANCOVA) models demonstrated that vitamin D supplementation over 12&#x000a0;weeks had no significant effect on VO<sub>2</sub> max (<italic>P</italic>&#x000a0;=&#x000a0;0.375), vertical jump height (<italic>P</italic>&#x000a0;=&#x000a0;0.797), left and right handgrip strength (<italic>P</italic>&#x000a0;=&#x000a0;0.146 and <italic>P</italic>&#x000a0;=&#x000a0;0.266, respectively), forced vital capacity (<italic>P</italic>&#x000a0;=&#x000a0;0.573) or forced expiratory volume at 1&#x000a0;s (<italic>P</italic>&#x000a0;=&#x000a0;0.665), after adjusting for confounders. The high prevalence of vitamin D inadequacy observed in this cohort of collegiate Gaelic footballers supports the need for vitamin D supplementation during wintertime to avoid being at risk of poor bone health.</p></sec><sec><title>Conclusions</title><p id="Par4">Twelve-week daily supplementation with 3000&#x000a0;IU (75&#x000a0;&#x000b5;g) vitamin D<sub>3</sub> successfully resolved deficiency but did not have any significant effect on VO<sub>2</sub> max, skeletal muscle or lung function.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Vitamin D</kwd><kwd>VO<sub>2</sub> max</kwd><kwd>Athletes</kwd><kwd>Randomised controlled trial</kwd><kwd>Football</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008303</institution-id><institution>Department for Employment and Learning, Northern Ireland</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag Berlin Heidelberg 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Vitamin D insufficiency and deficiency can be defined as a total serum 25-hydroxyvitamin D (25[OH]D) concentration below 50 and 30&#x000a0;nmol/L, respectively [<xref ref-type="bibr" rid="CR1">1</xref>]. Such low total 25(OH)D concentrations are widespread, and a growing number of studies around the globe have identified this health concern in athletes [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. Vitamin D and its metabolites are renowned for their pivotal role in establishing musculoskeletal health during childhood and adolescence and in hindering the development of skeletal pathology [<xref ref-type="bibr" rid="CR6">6</xref>]. In addition, a growing body of evidence has demonstrated the importance of vitamin D beyond bone health on immune, cardiopulmonary and skeletal muscle function [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par6">Biologically inactive total 25(OH)D is comprised of 25(OH)D<sub>2</sub> and 25(OH)D<sub>3</sub>, compounds that are both formed following hepatic hydroxylation of vitamin D<sub>2</sub> (ergocalciferol) and vitamin D<sub>3</sub> (cholecalciferol) [<xref ref-type="bibr" rid="CR8">8</xref>]. Ergocalciferol is derived from fungi exposed to ultraviolet B radiation (UVB) [<xref ref-type="bibr" rid="CR9">9</xref>]. In humans, cholecalciferol is produced following exposure of cutaneous cells to UVB at a wavelength of 290&#x02013;315&#x000a0;nm and is also present in oily fish, eggs and liver [<xref ref-type="bibr" rid="CR10">10</xref>]. Calcitriol (1,25-dihydroxyvitamin D (1,25[OH]<sub>2</sub>D) is formed subsequent to renal hydroxylation of 25(OH)D, and it is this hormonally active compound that has been implicated in numerous processes involving the immune, cardiovascular and respiratory systems [<xref ref-type="bibr" rid="CR11">11</xref>]. Binding of 1,25[OH]<sub>2</sub>D to its nuclear receptor (VDR) results in the formation of a VDR-retinoid X receptor (RXR) heterodimer that enables 1,25(OH)<sub>2</sub>D to act as a transcriptional regulator through binding to response elements located in the DNA of vitamin D target tissues [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par7">In observational studies of both athletes and non-athletes, total 25(OH)D concentration has been positively associated with measures of aerobic fitness although findings have not been consistent [<xref ref-type="bibr" rid="CR13">13</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>]. One such measure is VO<sub>2</sub> max, the maximal volume of oxygen utilised, per minute, during exhaustive exercise, which is considered the gold-standard measure of aerobic fitness and is related to distance covered in field games [<xref ref-type="bibr" rid="CR20">20</xref>]. VO<sub>2</sub> max is determined by a range of overriding factors including cardiac output, oxygen transit time and oxygen saturation [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par8">A major limitation of existing observational research in this area is its inability to determine causality, and therefore, it is not known whether total 25(OH)D concentration is a cause of increased VO<sub>2</sub> max or simply a result of reverse causation, perhaps owing to increased outdoor training time [<xref ref-type="bibr" rid="CR22">22</xref>]. Despite the paucity of randomised controlled trials investigating this relationship, there is significant evidence of mechanisms by which vitamin D may influence factors that determine VO<sub>2</sub> max [<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>]. One such mechanism is the ability of 1,25(OH)<sub>2</sub>D to suppress mRNA expression of hepcidin, the negative regulator of systemic iron concentration, an action which has been associated with increased expression of ferroportin in hepatocytes and monocytes [<xref ref-type="bibr" rid="CR24">24</xref>]. Ferroportin is the sole iron export protein in humans and plays a crucial role in maintaining erythropoiesis, a contributory factor to VO<sub>2</sub> max [<xref ref-type="bibr" rid="CR26">26</xref>&#x02013;<xref ref-type="bibr" rid="CR28">28</xref>]. Studies in both healthy adults and patients with chronic kidney disease have demonstrated that vitamin D supplementation significantly decreases systemic hepcidin concentrations [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Collectively, these findings raise the question as to whether optimising total 25(OH)D concentrations has a beneficial effect on VO<sub>2</sub> max in athletes.</p><p id="Par9">The primary aim of the current study was to test whether athletes who received daily vitamin D<sub>3</sub> supplementation at 3000&#x000a0;IU (75&#x000a0;&#x000b5;g) demonstrated a significant increase in VO<sub>2</sub> max compared to those provided with a placebo. Secondary aims were to determine whether supplementation influenced skeletal muscle and lung function.</p></sec><sec id="Sec2"><title>Experimental methods</title><p id="Par10">This 12-week parallel group, double-blind, randomised, placebo-controlled trial was conducted at the University of Ulster, Coleraine, at a latitude of 55&#x000b0;N between the months of November 2014 and April 2015. All procedures were approved by the University&#x02019;s Research Ethics Committee (REC/14/0087), and the study was registered at <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov">www.clinicaltrials.gov</ext-link> (NCT02278172) and conducted in accordance with the Declaration of Helsinki. The protocol consisted of a series of appointments to obtain fasted blood samples and other physical measurements before and after a 12-week intervention. Nutritional and exercise intervention studies in athletes and healthy adults have demonstrated that 12&#x000a0;weeks is a suitable duration to observe a meaningful change over time in VO<sub>2</sub> max [<xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>]. Yet the dose and duration of vitamin D supplementation required to have a significant impact on VO<sub>2</sub> max have not been investigated to date.</p><sec id="Sec3"><title>Subjects</title><p id="Par11">Apparently healthy male and female athletes over the age of 18 were considered suitable for inclusion. Exclusion criteria were as follows: not a member of a university sports team; vitamin D supplementation and/or iron supplementation in the 30&#x000a0;days prior to baseline measurements; health concern(s)/physical disabilities identified by the screening questionnaire that would prevent successful completion of the study; consumption of medication(s) known to influence vitamin D metabolism; vegan athletes; sun-bed users; those who had been on a sun holiday in the 30&#x000a0;days prior to baseline measurements; those planning a sun holiday for during the time frame of the study. Gaelic footballers from the university team (<italic>n</italic>&#x000a0;=&#x000a0;72) completed a screening questionnaire in the first instance. A total of 42 Gaelic footballers (<italic>n</italic>&#x000a0;=&#x000a0;18 males and <italic>n</italic>&#x000a0;=&#x000a0;24 females) were deemed eligible for inclusion and provided informed consent before commencing the study.</p></sec><sec id="Sec4"><title>Supplements and compliance</title><p id="Par12">An independent clinical trials manager used MINIM software [<xref ref-type="bibr" rid="CR32">32</xref>] to randomise recruited athletes into vitamin D (VD) or placebo (PL) groups, stratified by sex and with an allocation ratio of 1:1. All subjects and researchers were blinded to the allocations until completion of the study and subsequent data analysis. Footballers allocated to the VD group received an oral spray solution providing 3000&#x000a0;IU(75&#x000a0;&#x000b5;g) vitamin D<sub>3</sub> per spray, whereas those allocated to the PL group received an oral spray solution that did not contain vitamin D but was identical in appearance, smell, taste and from the same brand (BetterYou Ltd, Barnsley, UK). The dose provided was deemed suitable to raise total 25(OH)D concentrations to within the suggested range for extra-skeletal actions of vitamin D (75&#x02013;100&#x000a0;nmol/L) [<xref ref-type="bibr" rid="CR33">33</xref>&#x02013;<xref ref-type="bibr" rid="CR35">35</xref>]. The vitamin D<sub>3</sub> content of supplements was verified by an independent laboratory using high-performance liquid chromatography (Eurofins Product Testing, Cheshire, UK). Footballers were instructed to administer a single spray, targeting the buccal membrane, on a daily basis throughout the intervention and to return their used spray bottle at their final appointment. Percentage compliance was determined by applying the following equations.<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D = \left( {{\text{f}} - {\text{b}}} \right) - {\text{e}} \div s.$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mi>D</mml:mi><mml:mo>=</mml:mo><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mtext>f</mml:mtext><mml:mo>-</mml:mo><mml:mtext>b</mml:mtext></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:mtext>e</mml:mtext><mml:mo>&#x000f7;</mml:mo><mml:mi>s</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math><graphic xlink:href="394_2016_1202_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$C = D \div {\text{d}} \times 100.$$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:mi>D</mml:mi><mml:mo>&#x000f7;</mml:mo><mml:mtext>d</mml:mtext><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math><graphic xlink:href="394_2016_1202_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>In Eqs.&#x000a0;<xref rid="Equ1" ref-type="">1</xref> and <xref rid="Equ2" ref-type="">2</xref>, <italic>D</italic> is number of days the spray was taken; f refers to the filled weight of the spray bottle, and b is the empty spray bottle weight. e is the weight of the spray bottle upon study completion with <italic>s</italic> referring to the weight of each spray. In Eq.&#x000a0;<xref rid="Equ2" ref-type="">2</xref>, C is percentage compliance and d represents the number of days on intervention. Filled weights were based upon the manufacturer&#x02019;s specifications and the average weight of a random sample of 10 oral spray bottles from the supplied batch.</p></sec><sec id="Sec5"><title>Blood collection and processing</title><p id="Par13">Participants were instructed to fast from 10&#x000a0;pm the night prior to blood sampling, and regular water intake was encouraged. Fasted blood samples were obtained from the antecubital fossa using a 21-gauge butterfly needle and 8&#x000a0;mL serum and 9&#x000a0;mL ethylenediaminetetraacetic acid (EDTA) plasma vacutainer tubes (Greiner Bio-One GmbH, Kremsmunster, Austria). Following inversion, serum samples were allowed to clot for &#x0003c;60&#x000a0;min and plasma samples placed in refrigeration until centrifugation. Tubes were centrifuged at 2200&#x000a0;rpm for 15&#x000a0;min at 4&#x000a0;&#x000b0;C to allow separation of whole blood into its respective components. Following separation, serum and plasma samples were pipetted into 0.5&#x000a0;mL aliquots and stored at &#x02212;80&#x000a0;&#x000b0;C until further analysis.</p></sec><sec id="Sec6"><title>Blood analyses</title><p id="Par14">Liquid chromatography-tandem mass spectrometry (LCMS-MS) (API 4000; AB SCIEX) was used to quantify serum 25(OH)D<sub>2</sub> and 25(OH)D<sub>3</sub> concentrations, using a commercially available assay (Chromsystems Instruments and Chemicals GmbH; MassChrom 25-OH-Vitamin D<sub>3</sub>/D<sub>2</sub>). This analysis was undertaken at the Biochemistry Department of St James&#x02019; Hospital Dublin, a laboratory that complies with the Vitamin D External Quality Assessment Scheme and use of the National Institute of Standards and Technology 972 vitamin D standard reference material. The respective inter- and intra-assay coefficients of variation were 6.5 and 7.5&#x000a0;%. Plasma intact parathyroid hormone concentrations were measured, in duplicate, using a commercially available enzyme-linked immunosorbent assay (MD Biosciences Inc., Minnesota, USA). Intra and inter-assay coefficients of variation were 6.8 and 6.2&#x000a0;%, respectively. Calcium, albumin and creatinine concentrations were also measured in duplicate and assessed using an ILab 650 clinical biochemistry analyser (Instrumentation Laboratory, Massachusetts, USA). Intra-assay coefficients of variation were 0.65, 0.85 and 1.65&#x000a0;%, respectively. Intact parathyroid hormone and adjusted calcium concentrations were measured in order to ensure there were no adverse effects of the intervention such as hypoparathyroidism or hypercalcaemia [<xref ref-type="bibr" rid="CR36">36</xref>]. Impaired renal function can lead to deleterious effects on vitamin D metabolism, and therefore, the renal function of athletes&#x02019; was evaluated by estimating glomerular filtration rate (eGFR) adjusted for fat-free mass [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. This was quantified from serum creatinine concentrations using the Modification of Diet in Renal Disease (MDRD) equation [<xref ref-type="bibr" rid="CR39">39</xref>].</p></sec><sec id="Sec7"><title>Skeletal muscle function</title><p id="Par15">Average handgrip strength (kg) was measured using a dynamometer assembled at handgrip position 2 as default with shoulder flexion at 0&#x000ba; and elbow and wrist fully extended (Jamar Plus+, Patterson Medical, Warrenville, IL, USA) [<xref ref-type="bibr" rid="CR40">40</xref>]. Footballers held the device alongside their body and gripped maximally a total of 3 times. Average handgrip strength was calculated for analysis. Vertical jump height (cm) was measured using a calibrated electronic jump mat (FSL Electronics Ltd, Cookstown, UK). Footballers performed a counter-movement jump a total of 3 times, with best recorded jump height used for statistical analysis [<xref ref-type="bibr" rid="CR41">41</xref>]. A standardised rest period of 10&#x000a0;s was given between repeats of both handgrip and vertical jump tests.</p></sec><sec id="Sec8"><title>Lung function</title><p id="Par16">Footballers&#x02019; lung function was assessed using a calibrated MicroLab portable spirometer (Carefusion Corporation, San Diego, CA, USA). Forced vital capacity (FVC) and forced expiratory volume at 1&#x000a0;s (FEV<sub>1</sub>) were quantified by exhaling maximally into a 1-way disposable mouthpiece, and a minimum of 3 repeats was performed in order to derive average values.</p></sec><sec id="Sec9"><title>Maximal oxygen consumption</title><p id="Par17">Footballers refrained from heavy training/competition for at least 24&#x000a0;h prior to exercise testing, in order to control for last-bout effects. Pre- and post-intervention, subjects completed an incremental exercise test that was designed to elicit a VO<sub>2</sub> max response within the capabilities of the treadmill (MERC-C, WOODWAY GmbH, Germany). Gas analysis was performed using a metabolic cart that has been shown to give reliable measurements (Metalyzer 3B, CORTEX Biophysik GmbH, Germany) with calibrations for ambient conditions, analyser volume and concentrations of oxygen and carbon dioxide performed on a daily basis, prior to testing [<xref ref-type="bibr" rid="CR42">42</xref>]. Footballers wore an FT1 heart rate monitor (Polar Electro Ltd, Warwick, UK) and face mask with triple V insert. Following a standardised warm-up at 5&#x000a0;km/h (1&#x000a0;% incline), the test began at a running speed of 8&#x000a0;km/h (1&#x000a0;% incline) and speed increased by 1&#x000a0;km/h every minute until a running speed of 17&#x000a0;km/h was attained. At this point, running speed remained constant; however, incline increased by 1&#x000a0;% each minute until VO<sub>2</sub> max was achieved. The test was terminated upon volitional exhaustion or if any two of the following criteria were met: respiratory exchange ratio &#x0003e;1.15; oxygen plateau observed (i.e. no increase in oxygen consumption despite an increase in workload); heart rate &#x000b1;10&#x000a0;bpm of age-predicted maximum (208&#x000a0;&#x02212;&#x000a0;0.7&#x000a0;&#x000d7;&#x000a0;age) [<xref ref-type="bibr" rid="CR43">43</xref>]. Achievement of VO<sub>2</sub> max was further verified by determining post-exercise lactate concentrations, using a Lactate Pro device as per the manufacturers&#x02019; recommendations (Arkray Inc, Kyoto, Japan). Peak lactate concentrations are reached between 3 and 8&#x000a0;min post-exercise [<xref ref-type="bibr" rid="CR44">44</xref>]; therefore, at 5&#x000a0;min, following cessation of the VO<sub>2</sub> max test, a 6-&#x000b5;L capillary blood sample was obtained for lactate analysis. The lactate response to exercise may also vary according to age and sex. To account for this a blood lactate concentration &#x0003e;9&#x000a0;mmol/L in males and &#x0003e;7&#x000a0;mmol/L in females was considered as evidence of significant anaerobic metabolism [<xref ref-type="bibr" rid="CR45">45</xref>].</p></sec><sec id="Sec10"><title>Body composition</title><p id="Par18">Footballers&#x02019; height and weight were measured using a stadiometer and calibrated scales. Fat mass (FM) and fat-free mass (FFM) were measured by whole-body densitometry pre- and post-intervention (BOD POD, Life Measurement Inc, Concord, CA). The validity of this method has been reported extensively elsewhere [<xref ref-type="bibr" rid="CR46">46</xref>]. Footballers were asked to refrain from heavy physical activity for 24&#x000a0;h, and testing was performed following an overnight fast. Body mass was calculated using a calibrated electronic scale. Body volume was determined by air displacement plethysmography, corrected for predicted thoracic gas volume. The plethysmography chamber was calibrated using a 49.385-L cylinder as per manufacturers&#x02019; instructions. Percentage fat mass (%FM) was calculated using the Siri equation [<xref ref-type="bibr" rid="CR47">47</xref>]. Footballers wore tight-fitting clothing (i.e. swimsuit or compression garment with silicone swimming cap), to ensure an accurate measurement of body volume, and were instructed to sit upright and remain still throughout the test. A minimum of two measurements was taken per athlete. FM and FFM (kg) were adjusted for athlete&#x02019;s height (m<sup>2</sup>) and presented as fat mass index (FMI) and fat-free mass index (FFMI) (kg/m<sup>2</sup>) [<xref ref-type="bibr" rid="CR48">48</xref>].</p></sec><sec id="Sec11"><title>Dietary assessment</title><p id="Par19">In order to estimate dietary vitamin D intake, footballers completed a validated food frequency questionnaire (FFQ) [<xref ref-type="bibr" rid="CR49">49</xref>]. These data were collected on a single occasion due to the negligible contribution of dietary sources to total 25(OH)D concentration and the low intake of such foods in the Western diet [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>], despite a growing range of vitamin D-fortified products. Researchers asked players a series of questions relating to their consumption of food items known to contain vitamin D, with a photographic food atlas used to estimate portion sizes [<xref ref-type="bibr" rid="CR52">52</xref>].</p></sec><sec id="Sec12"><title>Physical activity</title><p id="Par20">The validated Recent Physical Activity Questionnaire (RPAQ), capable of assessing physical activity for the previous 4&#x000a0;weeks, was completed pre- and post-intervention to control for a change in moderate-vigorous physical activity during the study [<xref ref-type="bibr" rid="CR53">53</xref>]. Participants completed RPAQ questionnaires during appointments, and the researcher present queried any ambiguous responses prior to data entry.</p></sec><sec id="Sec13"><title>Statistical analysis</title><p id="Par21">An a priori power calculation with a two-sided 5&#x000a0;% significance level and power at 95&#x000a0;% determined that 35 athletes were required to observe a statistically significant 3.5&#x000a0;mL/kg/min increase in VO<sub>2</sub> max (G Power version 3.1) [<xref ref-type="bibr" rid="CR54">54</xref>]. The final number of recruited athletes (<italic>n</italic>&#x000a0;=&#x000a0;42) took into account an estimated dropout rate of 20&#x000a0;%. All statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS) with significance set at <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05 throughout (IBM SPSS Statistics for Windows, version 21.0, IBM Corp, Armonk, NY). In accordance with the Consolidated Standards of Reporting Trials (CONSORT) guidelines, analyses were conducted using the intention-to-treat (ITT) principle thereby including all athletes randomised at baseline (<italic>n</italic>&#x000a0;=&#x000a0;42) [<xref ref-type="bibr" rid="CR55">55</xref>]. Missing data for physical and biochemical measures were deemed to be missing completely at random, owing to injury or illness unrelated to the intervention, justifying the use of multiple imputation. The Shapiro&#x02013;Wilk test was used to determine whether data followed a normal distribution and skewed variables were transformed, using the logarithmic function, to attain a normal distribution prior to multiple imputation and further analysis. Transformations were applied to total 25(OH)D, creatinine and PTH concentrations as well as age and change in moderate-vigorous physical activity and FFMI. Multiple imputations consisted of 40 imputed data sets with pooled data used for subsequent analysis [<xref ref-type="bibr" rid="CR56">56</xref>]. Imputed data are outlined in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. Descriptive statistics were used to present participant characteristics at baseline. An independent <italic>t</italic> test or a Chi-square test was utilised to test for differences between VD and PL groups at baseline. ANCOVA models were used to assess the effect of intervention on VO<sub>2</sub> max and secondary outcome measures. Prognostic covariates were selected a priori for each model based upon evidence of a significant interaction between the covariate and dependent variable in question [<xref ref-type="bibr" rid="CR57">57</xref>&#x02013;<xref ref-type="bibr" rid="CR60">60</xref>]. Reliability of repeated skeletal muscle function tests was assessed by pooling pre- and post-intervention data in order to determine the standard error of measurement (SEM) and intra-class correlation coefficient (ICC) [<xref ref-type="bibr" rid="CR61">61</xref>]. These analyses were performed using the reliability test function in SPSS and SEM calculated by applying Cronbach&#x02019;s &#x003b1; to following equation. <inline-formula id="IEq1"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{SEM}} = {\text{SD}}\sqrt {(1 {-} r_{xx}^{2} )}$$\end{document}</tex-math><mml:math id="M6"><mml:mrow><mml:mtext>SEM</mml:mtext><mml:mo>=</mml:mo><mml:mtext>SD</mml:mtext><mml:msqrt><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msubsup><mml:mi>r</mml:mi><mml:mrow><mml:mi>x</mml:mi><mml:mi>x</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msqrt></mml:mrow></mml:math><inline-graphic xlink:href="394_2016_1202_Article_IEq1.gif"/></alternatives></inline-formula> where SEM is standard error of measurement, SD refers to the standard deviation of test scores, and <italic>r</italic>
<sub><italic>xx</italic></sub> refers to Cronbach&#x02019;s &#x003b1; as the reliability measure of test scores [<xref ref-type="bibr" rid="CR62">62</xref>].<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>CONSORT flow diagram. A total of 72 Gaelic footballers were assessed for eligibility with 30 excluded due to not meeting the inclusion criteria (<italic>n</italic>&#x000a0;=&#x000a0;7) or no longer wishing to participate (<italic>n</italic>&#x000a0;=&#x000a0;23). Remaining Gaelic footballers (<italic>n</italic>&#x000a0;=&#x000a0;42) were randomised to receive an oral spray solution containing either 3000&#x000a0;IU of vitamin D<sub>3</sub> (<italic>n</italic>&#x000a0;=&#x000a0;22) or placebo (<italic>n</italic>&#x000a0;=&#x000a0;20). A total of 7 athletes were lost to follow-up owing to illness (<italic>n</italic>&#x000a0;=&#x000a0;1) unrelated to the intervention, sun holiday (<italic>n</italic>&#x000a0;=&#x000a0;1) or no longer wishing to participate (<italic>n</italic>&#x000a0;=&#x000a0;5). A total of 35 athletes completed the study per protocol (vitamin D treatment group <italic>n</italic>&#x000a0;=&#x000a0;18 and placebo <italic>n</italic>&#x000a0;=&#x000a0;17). All footballers randomised at baseline were included in the final analysis (<italic>n</italic>&#x000a0;=&#x000a0;42)</p></caption><graphic xlink:href="394_2016_1202_Fig1_HTML" id="MO3"/></fig>
</p></sec></sec><sec id="Sec14"><title>Results</title><p id="Par22">A total of 7 footballers were absent to follow-up (<italic>n</italic>&#x000a0;=&#x000a0;5 VD and <italic>n</italic>&#x000a0;=&#x000a0;2 PL) due to sun holidays or illness unrelated to the intervention. Use of ITT did not change the outcome of the study when compared with <italic>per protocol</italic> analysis. There was no significant difference in the ratio of male to female subjects between groups (males <italic>n</italic>&#x000a0;=&#x000a0;12 and females <italic>n</italic>&#x000a0;=&#x000a0;10 VD; males <italic>n</italic>&#x000a0;=&#x000a0;6 and females <italic>n</italic>&#x000a0;=&#x000a0;14 PL) <italic>P</italic>&#x000a0;=&#x000a0;0.857. The participant flow throughout the study is summarised in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. Footballers&#x02019; biochemical and physical characteristics at baseline and week 12 are provided in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. The average rate of compliance to the intervention was 95&#x000a0;%. At baseline, 50 and 22&#x000a0;% of athletes presented with vitamin D insufficiency (31&#x02013;49&#x000a0;nmol/L) and deficiency (&#x0003c;30&#x000a0;nmol/L), respectively. The effect of the intervention on outcome measures at week 12, after adjusting for covariates, is detailed in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. Supplementation significantly increased total 25(OH)D concentrations in the VD group compared to PL group, <italic>P</italic>&#x000a0;=&#x000a0;0.006, and resolved vitamin D deficiency in all athletes allocated to VD. There was no correlation between total 25(OH)D and measures of physical performance at either time point, <italic>P</italic>&#x000a0;&#x0003e;&#x000a0;0.05. Furthermore, supplementation with vitamin D<sub>3</sub> did not significantly increase VO<sub>2</sub> max compared to the PL group, <italic>P</italic>&#x000a0;=&#x000a0;0.375. Vitamin D<sub>3</sub> supplementation did not significantly increase vertical jump height when compared to the PL group, <italic>P</italic>&#x000a0;=&#x000a0;0.797, and also had no significant effect on left or right handgrip strength, <italic>P</italic>&#x000a0;=&#x000a0;0.146 and <italic>P</italic>&#x000a0;=&#x000a0;0.266, respectively. SEM and ICC results for vertical jump height (SEM&#x000a0;=&#x000a0;1.51, <italic>r</italic>&#x000a0;=&#x000a0;0.95), left and right handgrip strength (SEM&#x000a0;=&#x000a0;2.06, <italic>r</italic>&#x000a0;=&#x000a0;0.96 and SEM&#x000a0;=&#x000a0;2.34, <italic>r</italic>&#x000a0;=&#x000a0;0.95, respectively) indicated a strong internal consistency across repeated skeletal muscle function tests. Supplementation with vitamin D<sub>3</sub> did not have a significant effect upon either measure of footballers lung function compared to those allocated to PL, FVC <italic>P</italic>&#x000a0;=&#x000a0;0.573 and FEV<sub>1</sub>
<italic>P</italic>&#x000a0;=&#x000a0;0.665. There were no adverse health effects to supplementation demonstrated by normal adjusted calcium and PTH concentrations at week 12.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Footballers&#x02019; characteristics at baseline and week 12 expressed as mean&#x000a0;&#x000b1;&#x000a0;standard deviation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Treatment group</th><th align="left" colspan="2">Vitamin D (<italic>n</italic>&#x000a0;=&#x000a0;22)</th><th align="left" colspan="2">Placebo (<italic>n</italic>&#x000a0;=&#x000a0;20)</th><th align="left" rowspan="2">
<italic>P</italic>
</th><th align="left" rowspan="2">
<italic>P</italic>
</th></tr><tr><th align="left">Measure</th><th align="left">Baseline</th><th align="left">Week 12</th><th align="left">Baseline</th><th align="left">Week 12</th></tr></thead><tbody><tr><td align="left">Age, year</td><td char="&#x000b1;" align="char">20&#x000a0;&#x000b1;&#x000a0;2</td><td align="left">&#x02013;</td><td char="&#x000b1;" align="char">20&#x000a0;&#x000b1;&#x000a0;2</td><td align="left">&#x02013;</td><td align="left">0.819</td><td align="left">&#x02013;</td></tr><tr><td align="left">Height, cm</td><td char="&#x000b1;" align="char">171.39&#x000a0;&#x000b1;&#x000a0;8.65</td><td align="left">&#x02013;</td><td char="&#x000b1;" align="char">165.65&#x000a0;&#x000b1;&#x000a0;10.18</td><td align="left">&#x02013;</td><td align="left">0.048<sup>a</sup>
</td><td align="left">&#x02013;</td></tr><tr><td align="left">Weight, kg</td><td char="&#x000b1;" align="char">70.52&#x000a0;&#x000b1;&#x000a0;11.49</td><td align="left">71.1&#x000a0;&#x000b1;&#x000a0;11.91</td><td char="&#x000b1;" align="char">61.92&#x000a0;&#x000b1;&#x000a0;10.69</td><td align="left">62.30&#x000a0;&#x000b1;&#x000a0;10.56</td><td align="left">0.009<sup>a</sup>
</td><td align="left">0.493</td></tr><tr><td align="left">BMI, kg/m<sup>2</sup>
</td><td char="&#x000b1;" align="char">23.89&#x000a0;&#x000b1;&#x000a0;2.66</td><td align="left">24.30&#x000a0;&#x000b1;&#x000a0;2.82</td><td char="&#x000b1;" align="char">22.31&#x000a0;&#x000b1;&#x000a0;2.19</td><td align="left">22.57&#x000a0;&#x000b1;&#x000a0;2.35</td><td align="left">0.031<sup>a</sup>
</td><td align="left">0.605</td></tr><tr><td align="left">Fat mass index, kg/m<sup>2</sup>
</td><td char="&#x000b1;" align="char">5.23&#x000a0;&#x000b1;&#x000a0;2.71</td><td align="left">5.70&#x000a0;&#x000b1;&#x000a0;2.97</td><td char="&#x000b1;" align="char">5.81&#x000a0;&#x000b1;&#x000a0;1.94</td><td align="left">5.76&#x000a0;&#x000b1;&#x000a0;2.03</td><td align="left">0.439</td><td align="left">0.047<sup>b</sup>
</td></tr><tr><td align="left">Fat-free mass index, kg/m<sup>2</sup>
</td><td char="&#x000b1;" align="char">18.95&#x000a0;&#x000b1;&#x000a0;3.11</td><td align="left">18.34&#x000a0;&#x000b1;&#x000a0;2.51</td><td char="&#x000b1;" align="char">16.46&#x000a0;&#x000b1;&#x000a0;1.88</td><td align="left">16.89&#x000a0;&#x000b1;&#x000a0;2.12</td><td align="left">0.004<sup>a</sup>
</td><td align="left">0.082</td></tr><tr><td align="left">Total 25(OH)D, nmol/L</td><td char="&#x000b1;" align="char">47.37&#x000a0;&#x000b1;&#x000a0;13.29</td><td align="left">83.68&#x000a0;&#x000b1;&#x000a0;32.98</td><td char="&#x000b1;" align="char">43.10&#x000a0;&#x000b1;&#x000a0;22.00</td><td align="left">49.22&#x000a0;&#x000b1;&#x000a0;25.40</td><td align="left">0.183</td><td align="left">0.001<sup>b</sup>
</td></tr><tr><td align="left">25(OH)D<sub>2</sub>, nmol/L</td><td char="&#x000b1;" align="char">2.85&#x000a0;&#x000b1;&#x000a0;1.83</td><td align="left">1.91&#x000a0;&#x000b1;&#x000a0;2.03</td><td char="&#x000b1;" align="char">2.17&#x000a0;&#x000b1;&#x000a0;1.96</td><td align="left">2.89&#x000a0;&#x000b1;&#x000a0;1.90</td><td align="left">0.313</td><td align="left">0.009<sup>b</sup>
</td></tr><tr><td align="left">25(OH)D<sub>3</sub>, nmol/L</td><td char="&#x000b1;" align="char">44.49&#x000a0;&#x000b1;&#x000a0;13.35</td><td align="left">81.77&#x000a0;&#x000b1;&#x000a0;33.66</td><td char="&#x000b1;" align="char">40.93&#x000a0;&#x000b1;&#x000a0;22.09</td><td align="left">46.33&#x000a0;&#x000b1;&#x000a0;25.64</td><td align="left">0.225</td><td align="left">0.001<sup>b</sup>
</td></tr><tr><td align="left">Vitamin D intake, &#x000b5;g/day</td><td char="&#x000b1;" align="char">6.73&#x000a0;&#x000b1;&#x000a0;5.33</td><td align="left">&#x02013;</td><td char="&#x000b1;" align="char">4.93&#x000a0;&#x000b1;&#x000a0;2.47</td><td align="left">&#x02013;</td><td align="left">0.227</td><td align="left">&#x02013;</td></tr><tr><td align="left">PTH, g/dL</td><td char="&#x000b1;" align="char">41.21&#x000a0;&#x000b1;&#x000a0;15.98</td><td align="left">42.24&#x000a0;&#x000b1;&#x000a0;20.96</td><td char="&#x000b1;" align="char">39.28&#x000a0;&#x000b1;&#x000a0;19.12</td><td align="left">43.93&#x000a0;&#x000b1;&#x000a0;23.65</td><td align="left">0.502</td><td align="left">0.204</td></tr><tr><td align="left">Adjusted calcium, mmol/L</td><td char="&#x000b1;" align="char">2.29&#x000a0;&#x000b1;&#x000a0;0.07</td><td align="left">2.29&#x000a0;&#x000b1;&#x000a0;0.09</td><td char="&#x000b1;" align="char">2.29&#x000a0;&#x000b1;&#x000a0;0.08</td><td align="left">2.31&#x000a0;&#x000b1;&#x000a0;0.08</td><td align="left">0.961</td><td align="left">0.427</td></tr><tr><td align="left">Creatinine, mmol/L</td><td char="&#x000b1;" align="char">98.81&#x000a0;&#x000b1;&#x000a0;11.51</td><td align="left">99.21&#x000a0;&#x000b1;&#x000a0;14.10</td><td char="&#x000b1;" align="char">89.20&#x000a0;&#x000b1;&#x000a0;7.10</td><td align="left">90.30&#x000a0;&#x000b1;&#x000a0;9.33</td><td align="left">0.001<sup>a</sup>
</td><td align="left">0.580</td></tr><tr><td align="left">Adjusted eGFR, mL/min/1.73&#x000a0;m<sup>3</sup>
</td><td char="&#x000b1;" align="char">94.10&#x000a0;&#x000b1;&#x000a0;9.30</td><td align="left">94.92&#x000a0;&#x000b1;&#x000a0;15.80</td><td char="&#x000b1;" align="char">98.10&#x000a0;&#x000b1;&#x000a0;9.76</td><td align="left">97.10&#x000a0;&#x000b1;&#x000a0;11.89</td><td align="left">0.439</td><td align="left">0.522</td></tr><tr><td align="left">Physical activity, h/day</td><td char="&#x000b1;" align="char">1.06&#x000a0;&#x000b1;&#x000a0;1.04</td><td align="left">0.70&#x000a0;&#x000b1;&#x000a0;0.59</td><td char="&#x000b1;" align="char">0.88&#x000a0;&#x000b1;&#x000a0;0.89</td><td align="left">0.51&#x000a0;&#x000b1;&#x000a0;0.47</td><td align="left">0.466</td><td align="left">0.749</td></tr><tr><td align="left">VO<sub>2</sub> max, mL/kg/min</td><td char="&#x000b1;" align="char">50.46&#x000a0;&#x000b1;&#x000a0;6.97</td><td align="left">50.41&#x000a0;&#x000b1;&#x000a0;6.96</td><td char="&#x000b1;" align="char">51.66&#x000a0;&#x000b1;&#x000a0;6.79</td><td align="left">49.33&#x000a0;&#x000b1;&#x000a0;5.92</td><td align="left">0.961</td><td align="left">0.176</td></tr><tr><td align="left">FEV<sub>1</sub>, L</td><td char="&#x000b1;" align="char">3.58&#x000a0;&#x000b1;&#x000a0;1.03</td><td align="left">3.47&#x000a0;&#x000b1;&#x000a0;0.73</td><td char="&#x000b1;" align="char">3.13&#x000a0;&#x000b1;&#x000a0;0.81</td><td align="left">3.25&#x000a0;&#x000b1;&#x000a0;0.86</td><td align="left">0.125</td><td align="left">0.311</td></tr><tr><td align="left">FVC, L</td><td char="&#x000b1;" align="char">4.20&#x000a0;&#x000b1;&#x000a0;1.06</td><td align="left">3.85&#x000a0;&#x000b1;&#x000a0;0.92</td><td char="&#x000b1;" align="char">3.40&#x000a0;&#x000b1;&#x000a0;0.96</td><td align="left">3.58&#x000a0;&#x000b1;&#x000a0;1.03</td><td align="left">0.014<sup>a</sup>
</td><td align="left">0.004<sup>b</sup>
</td></tr><tr><td align="left">FEV<sub>1</sub>:FVC, %</td><td char="&#x000b1;" align="char">86.10&#x000a0;&#x000b1;&#x000a0;14.44</td><td align="left">90.41&#x000a0;&#x000b1;&#x000a0;6.94</td><td char="&#x000b1;" align="char">93.02&#x000a0;&#x000b1;&#x000a0;6.10</td><td align="left">92.14&#x000a0;&#x000b1;&#x000a0;5.41</td><td align="left">0.050<sup>a</sup>
</td><td align="left">0.115</td></tr><tr><td align="left">Vertical jump height, cm</td><td char="&#x000b1;" align="char">31.71&#x000a0;&#x000b1;&#x000a0;8.32</td><td align="left">32.15&#x000a0;&#x000b1;&#x000a0;8.91</td><td char="&#x000b1;" align="char">27.36&#x000a0;&#x000b1;&#x000a0;6.49</td><td align="left">28.85&#x000a0;&#x000b1;&#x000a0;6.99</td><td align="left">0.068</td><td align="left">0.619</td></tr><tr><td align="left">Left handgrip strength, kg</td><td char="&#x000b1;" align="char">36.78&#x000a0;&#x000b1;&#x000a0;10.04</td><td align="left">36.77&#x000a0;&#x000b1;&#x000a0;11.05</td><td char="&#x000b1;" align="char">29.71&#x000a0;&#x000b1;&#x000a0;11.56</td><td align="left">32.98&#x000a0;&#x000b1;&#x000a0;11.30</td><td align="left">0.039<sup>a</sup>
</td><td align="left">0.076</td></tr><tr><td align="left">Right handgrip strength, kg</td><td char="&#x000b1;" align="char">39.29&#x000a0;&#x000b1;&#x000a0;10.57</td><td align="left">39.51&#x000a0;&#x000b1;&#x000a0;10.76</td><td char="&#x000b1;" align="char">30.54&#x000a0;&#x000b1;&#x000a0;11.33</td><td align="left">30.07&#x000a0;&#x000b1;&#x000a0;11.30</td><td align="left">0.013<sup>a</sup>
</td><td align="left">0.091</td></tr></tbody></table><table-wrap-foot><p>
<italic>BMI</italic> body mass index, <italic>25</italic>(<italic>OH</italic>)<italic>D</italic> 25-hydroxyvitamin D, <italic>PTH</italic> parathyroid hormone, <italic>eGFR</italic> estimated glomerular filtration rate, <italic>VO</italic>
<sub>2</sub>
<italic>max</italic> maximal oxygen uptake, <italic>FEV</italic>
<sub>1</sub> forced expiratory volume at 1&#x000a0;s, <italic>FVC</italic> forced vital capacity, <italic>FEV</italic>
<sub>1</sub>:<italic>FVC</italic> ratio of forced expiratory volume at 1&#x000a0;s to forced vital capacity</p><p>
<sup>a</sup>Significant difference between groups at baseline using an independent <italic>t</italic> test, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05</p><p>
<sup>b</sup>Significant change over time between groups using an ANOVA for normally distributed and transformed data, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Effect of intervention on outcome measures at week 12 expressed as mean&#x000a0;&#x000b1;&#x000a0;standard deviation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Treatment group</th><th align="left">Vitamin D (<italic>n</italic>&#x000a0;=&#x000a0;22)</th><th align="left">Placebo (<italic>n</italic>&#x000a0;=&#x000a0;20)</th><th align="left" colspan="3">ANCOVA test statistics</th></tr><tr><th align="left">Dependent variable</th><th align="left">Change from baseline</th><th align="left">Change from baseline</th><th align="left">
<italic>F</italic>
</th><th align="left">
<italic>r</italic>
<sup>2</sup>
</th><th align="left">
<italic>P</italic>
</th></tr></thead><tbody><tr><td align="left">Total 25(OH)D, nmol/L</td><td char="&#x000b1;" align="char">36.31&#x000a0;&#x000b1;&#x000a0;32.34</td><td char="&#x000b1;" align="char">6.11&#x000a0;&#x000b1;&#x000a0;23.93</td><td char="." align="char">15.98</td><td char="." align="char">0.396</td><td char="." align="char">0.006<sup>a, b</sup>
</td></tr><tr><td align="left">VO<sub>2</sub> max, mL/kg/min</td><td char="&#x000b1;" align="char">&#x02212;0.64&#x000a0;&#x000b1;&#x000a0;1.04</td><td char="&#x000b1;" align="char">&#x02212;2.00&#x000a0;&#x000b1;&#x000a0;0.96</td><td char="." align="char">1.12</td><td char="." align="char">0.535</td><td char="." align="char">0.375<sup>c</sup>
</td></tr><tr><td align="left">FEV<sub>1</sub>, L</td><td char="&#x000b1;" align="char">&#x02212;0.12&#x000a0;&#x000b1;&#x000a0;0.73</td><td char="&#x000b1;" align="char">0.12&#x000a0;&#x000b1;&#x000a0;0.55</td><td char="." align="char">0.36</td><td char="." align="char">0.520</td><td char="." align="char">0.665<sup>d</sup>
</td></tr><tr><td align="left">FVC, L</td><td char="&#x000b1;" align="char">&#x02212;0.35&#x000a0;&#x000b1;&#x000a0;0.73</td><td char="&#x000b1;" align="char">0.18&#x000a0;&#x000b1;&#x000a0;0.66</td><td char="." align="char">1.59</td><td char="." align="char">0.569</td><td char="." align="char">0.573<sup>d</sup>
</td></tr><tr><td align="left">Vertical jump height, cm</td><td char="&#x000b1;" align="char">0.42&#x000a0;&#x000b1;&#x000a0;6.59</td><td char="&#x000b1;" align="char">1.51&#x000a0;&#x000b1;&#x000a0;6.95</td><td char="." align="char">0.09</td><td char="." align="char">0.350</td><td char="." align="char">0.797<sup>e</sup>
</td></tr><tr><td align="left">Left handgrip strength, kg</td><td char="&#x000b1;" align="char">&#x02212;0.03&#x000a0;&#x000b1;&#x000a0;5.51</td><td char="&#x000b1;" align="char">3.30&#x000a0;&#x000b1;&#x000a0;5.98</td><td char="." align="char">2.40</td><td char="." align="char">0.665</td><td char="." align="char">0.146<sup>e</sup>
</td></tr><tr><td align="left">Right handgrip strength, kg</td><td char="&#x000b1;" align="char">0.18&#x000a0;&#x000b1;&#x000a0;5.64</td><td char="&#x000b1;" align="char">3.56&#x000a0;&#x000b1;&#x000a0;6.69</td><td char="." align="char">1.43</td><td char="." align="char">0.627</td><td char="." align="char">0.266<sup>e</sup>
</td></tr></tbody></table><table-wrap-foot><p>25(<italic>OH</italic>)<italic>D</italic> 25-hydroxyvitamin D, <italic>VO</italic>
<sub>2</sub>
<italic>max</italic> maximal oxygen uptake, <italic>FEV</italic>
<sub>1</sub> forced expiratory volume at 1&#x000a0;s, <italic>FVC</italic> forced vital capacity</p><p>
<sup>a</sup>Significant effect of treatment after adjusting for covariates, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05</p><p>
<sup>b</sup>Adjusting for total 25(OH)D concentration pre-intervention</p><p>
<sup>c</sup>Adjusting for VO<sub>2</sub> max pre-intervention and change in physical activity and FFMI</p><p>
<sup>d</sup>Adjusting for FEV<sub>1</sub> or FVC pre-intervention, BMI and change in physical activity</p><p>
<sup>e</sup>Adjusting for vertical jump height or handgrip strength pre-intervention, change in FFMI, FMI and physical activity</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec15"><title>Discussion</title><p id="Par23">This is not only the largest investigation of vitamin D supplementation on VO<sub>2</sub> max in athletes to date but also the first randomised controlled trial to successfully optimise vitamin D status using an oral spray solution. In this study, over half of the total cohort presented with vitamin D insufficiency or deficiency at baseline (50 and 22&#x000a0;%, respectively). Such findings corroborate existing literature [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR5">5</xref>], reiterating that athletes are a population that may be at risk of poor bone health, owing to total 25(OH)D concentrations below 50&#x000a0;nmol/L [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. Our previous research identified this health concern in elite Gaelic footballers, a finding now corroborated in those competing at the collegiate level [<xref ref-type="bibr" rid="CR3">3</xref>]. Twelve-week vitamin D<sub>3</sub> supplementation using a 3000&#x000a0;IU (75&#x000a0;&#x000b5;g) oral spray solution resolved vitamin D deficiency and increased mean total serum 25(OH)D concentrations to over 80&#x000a0;nmol/L. Conversely, those allocated to the PL treatment group remained at potential risk of poor bone health with a mean total 25(OH)D concentration below 50&#x000a0;nmol/L at week twelve [<xref ref-type="bibr" rid="CR65">65</xref>]. In contrast, Storlie et al. [<xref ref-type="bibr" rid="CR66">66</xref>] reported no significant change in total 25(OH)D concentrations over 12&#x000a0;weeks in athletes supplemented daily with a 1000&#x000a0;IU (25&#x000a0;&#x000b5;g) vitamin D<sub>3</sub> oral spray compared to placebo, supporting 3000&#x000a0;IU (75&#x000a0;&#x000b5;g) as an effective wintertime dosage. There is ongoing debate over what constitutes an optimal total 25(OH)D concentration for athletes. Some speculate that higher total 25(OH)D concentrations in excess of 100&#x000a0;nmol/L may be necessary to trigger the purported extra-skeletal benefits of vitamin D in athletes [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR68">68</xref>], though there is currently a lack of strong evidence for a benefit of maintaining total 25(OH)D concentrations above this threshold [<xref ref-type="bibr" rid="CR35">35</xref>]. Furthermore, toxicity manifests itself as hypercalcaemia and increased bone resorption at vitamin D supplementation doses exceeding 10,000&#x000a0;IU/day (250&#x000a0;&#x000b5;g) or a total 25(OH)D concentration &#x02248;750&#x000a0;nmol/L [<xref ref-type="bibr" rid="CR69">69</xref>]. Indeed, there was a significant change in FMI over the 12-week intervention period. FMI increased in the VD group but declined in the PL group. Although in-season, this finding may be explained by differences in the footballers&#x02019; individual training and conditioning programmes during the winter months in the absence of scheduled training sessions at the university.</p><p id="Par24">Mechanistic studies support the concept that vitamin D may influence VO<sub>2</sub> max through direct and indirect actions on iron metabolism [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Nevertheless, studies investigating the potential link between total 25(OH)D concentration and VO<sub>2</sub> max in vivo have yielded equivocal findings to date with many failing to account for important covariates such as PTH concentrations and participation in moderate-vigorous physical activity [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR70">70</xref>&#x02013;<xref ref-type="bibr" rid="CR75">75</xref>]. Moreover, universal criteria for VO<sub>2</sub> max have not been firmly established and therefore this may contribute to variation in study outcomes. Total 25(OH)D concentration was not associated with VO<sub>2</sub> max at either time point in the current study, a finding that is supported by Fitzgerald et al. 2014 and research conducted in healthy adults [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. In contrast, at a latitude of 35&#x000b0;N, Koundourakis and colleagues reported positive bivariate correlations between total 25(OH)D concentration and the VO<sub>2</sub> max of elite footballers, before and after a tapering period spanning the months of June and July [<xref ref-type="bibr" rid="CR17">17</xref>]. During this time, there was a small yet significant decrease in athlete&#x02019;s VO<sub>2</sub> max despite a concomitant increase in total 25(OH)D concentrations, likely owing to a reduced training load. Such findings indicate that vitamin D does not play a supportive role in determining VO<sub>2</sub> max in athletes, a concept that is substantiated by findings of the current study. Supplementation did not significantly increase VO<sub>2</sub> max compared to the PL group despite increasing total 25(OH)D concentration by 77&#x000a0;%, a finding that has also been shown by others [<xref ref-type="bibr" rid="CR76">76</xref>]. This contrasts with some randomised controlled trials of patients with cardiorespiratory pathology, although findings have not been consistent [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. Established primary determinants of VO<sub>2</sub> max include cardiac output and oxygen diffusion capacity [<xref ref-type="bibr" rid="CR21">21</xref>], and a possible explanation for the disparity between athletes and patients may be that athletes have a smaller ability to improve VO<sub>2</sub> max, owing to significant cardiovascular adaptations to aerobic training including enhanced cardiac output and capillary density [<xref ref-type="bibr" rid="CR79">79</xref>]. It is plausible that such adaptations may outweigh any potential benefit of vitamin D supplementation on VO<sub>2</sub> max when compared to patients with diminished cardiac output and/or oxygen diffusion capacity.</p><p id="Par25">The in vitro mechanisms by which vitamin D, specifically 1,25(OH)<sub>2</sub>D, may impact upon the skeletal muscle function of athletes have been reviewed extensively elsewhere, although less is known about the effects of vitamin D supplementation on skeletal muscle function in vivo [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR80">80</xref>]. Indeed, the effects of vitamin D supplementation on skeletal muscle function in athletes have been investigated before, albeit without taking into account change in physical activity or body composition, confounders that determine skeletal muscle function and may therefore mask a null effect of treatment [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. Total 25(OH)D concentration was not associated with any measure of skeletal muscle function in the current study, and supplementation did not significantly increase vertical jump height or handgrip strength when compared to PL, corroborating findings from a recent randomised controlled trial conducted in adolescent swimmers [<xref ref-type="bibr" rid="CR83">83</xref>]. These results demonstrate that vitamin D<sub>3</sub> supplementation does not enhance skeletal muscle function in younger adults after taking into account change in FMI, FFMI and moderate-vigorous physical activity, despite increasing total 25(OH)D concentrations to over 80&#x000a0;nmol/L. This contrasts with large studies of elderly patients that have identified a beneficial effect of vitamin D and calcium supplementation on skeletal muscle function and risk of falls [<xref ref-type="bibr" rid="CR84">84</xref>&#x02013;<xref ref-type="bibr" rid="CR86">86</xref>]. Aside from differences in the supplementation regime it is possible to speculate, based on the results of the current study and existing literature, that vitamin D<sub>3</sub> supplementation only benefits skeletal muscle in those with diminished function, explaining why no ergogenic effect was observed in this cohort of trained footballers. Another consideration is that the time taken for supplementation to increase total 25(OH)D concentrations to over 50&#x000a0;nmol/L, within the 12-week intervention, is not known. Therefore, it is possible that supplementation only increased total 25(OH)D concentrations to above 50&#x000a0;nmol/L late in the intervention, leaving little time for a measurable effect on skeletal muscle function parameters.</p><p id="Par26">Emerging research also posits that total 25(OH)D concentrations may be related to lung function, especially in those with airway disease [<xref ref-type="bibr" rid="CR87">87</xref>&#x02013;<xref ref-type="bibr" rid="CR89">89</xref>]. Potential mechanisms include enhanced innate immunity and downregulation of the T helper 1 cell response, resulting in less airway inflammation and a consequent improvement in overall airway function [<xref ref-type="bibr" rid="CR90">90</xref>]. Nevertheless, this study did not observe an association between total 25(OH)D concentration and measures of lung function at either time point and, in adjusted analyses, supplementation with vitamin D<sub>3</sub> did not significantly impact upon FEV<sub>1</sub> or FVC when compared to PL. In unadjusted analyses, there was a significant decrease in FVC over time in the VD group compared to those allocated to PL yet this was not the case in adjusted analyses indicating that the intervention did not have an adverse effect. These findings suggest that the response to vitamin D<sub>3</sub> supplementation, in terms of benefits on lung function parameters, may differ between healthy individuals and those with airway disease although larger studies, adjusting for lung function specific confounders are required.</p><p id="Par27">To our knowledge this is the first study to investigate the effects of vitamin D<sub>3</sub> supplementation on VO<sub>2</sub> max in athletes that has adjusted for key component covariates. Strengths of the study include a gender balance of athletes, accurate recording of compliance, independently verifying the vitamin D<sub>3</sub> content of supplements and being adequately powered to detect any potential significant change in VO<sub>2</sub> max. Due to the heterogeneous athlete population it is not known whether our findings translate to non-Caucasian athletes or those from endurance or strength-based disciplines. The VO<sub>2</sub> max test used in the current study was not validated. Future studies in this area are encouraged to utilise a validated protocol. The sample size for this study was specific to the primary outcome measure, VO<sub>2</sub> max. Further research with larger sample sizes may therefore be required in order to categorically rule out a beneficial effect of vitamin D supplementation on skeletal muscle and lung function in athletes. Future studies may also wish to consider stratifying by weight as well as sex to prevent differences between treatment groups at baseline.</p><p id="Par28">In conclusion, this study observed a high prevalence of vitamin D insufficiency and deficiency in collegiate Gaelic footballers during wintertime and such individuals should consider vitamin D supplementation to avoid being at risk of poor bone health. Twelve-week daily supplementation with a 3000&#x000a0;IU (75&#x000a0;&#x000b5;g) vitamin D<sub>3</sub> oral spray solution is an appropriate method, dose and duration to resolve deficiency and increase total 25(OH)D concentrations to over 80&#x000a0;nmol/L. However, vitamin D supplementation, at the dose provided here for 12&#x000a0;weeks, did not have any beneficial effect on VO<sub>2</sub> max, skeletal muscle or lung function in this cohort of Gaelic footballers.</p></sec></body><back><ack><p>The authors would like to thank the Department for Employment and Learning for supporting this research and BetterYou Ltd for gifting the oral spray solutions. The authors would like to thank Aaron Ballantyne and Dr Julie Sittlington for their advice and support with VO<sub>2</sub> max testing and all athletes involved in the study. PM was the principle investigator. JT, EMcS, LKP, PM and SM conceived of the study design. JT was responsible for data collection and performed statistical analysis. MH and EL were responsible for vitamin D analyses. All authors read and approved the final manuscript.</p></ack><notes notes-type="COI-statement"><title>Compliance with ethical standards</title><sec id="FPar1"><title>Conflict of interest</title><p id="Par29">The authors have no financial or personal conflicts of interest to declare in relation to this article.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>IOM (Institute of Medicine)</collab></person-group><source>Dietary reference intakes for calcium and vitamin D</source><year>2011</year><publisher-loc>Washington</publisher-loc><publisher-name>The National Academies Press</publisher-name></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holick</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name></person-group><article-title>Vitamin D deficiency: a worldwide problem with health consequences</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>87</volume><issue>4</issue><fpage>1080S</fpage><lpage>1086S</lpage><pub-id pub-id-type="pmid">18400738</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magee</surname><given-names>PJ</given-names></name><name><surname>Pourshahidi</surname><given-names>LK</given-names></name><name><surname>Wallace</surname><given-names>JMW</given-names></name><name><surname>Cleary</surname><given-names>J</given-names></name><name><surname>Conway</surname><given-names>J</given-names></name><name><surname>Harney</surname><given-names>E</given-names></name><etal/></person-group><article-title>Vitamin D status and supplementation in elite Irish athletes</article-title><source>Int J Sport Nutr Exerc Metab</source><year>2013</year><volume>23</volume><issue>5</issue><fpage>441</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1123/ijsnem.23.5.441</pub-id><pub-id pub-id-type="pmid">23535936</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villacis</surname><given-names>D</given-names></name><name><surname>Yi</surname><given-names>A</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Kephart</surname><given-names>C</given-names></name><name><surname>Charlton</surname><given-names>T</given-names></name><name><surname>Gamradt</surname><given-names>S</given-names></name><etal/></person-group><article-title>Prevalence of abnormal vitamin D levels among division I NCAA athletes</article-title><source>Sports Health</source><year>2014</year><volume>6</volume><issue>4</issue><fpage>640</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1177/1941738114524517</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrokhyar</surname><given-names>F</given-names></name><name><surname>Tabasinejad</surname><given-names>R</given-names></name><name><surname>Dao</surname><given-names>D</given-names></name><name><surname>Peterson</surname><given-names>D</given-names></name><name><surname>Ayeni</surname><given-names>O</given-names></name><name><surname>Hadioonzadeh</surname><given-names>R</given-names></name><etal/></person-group><article-title>Prevalence of vitamin D inadequacy in athletes: a systematic-review and meta-analysis</article-title><source>Sports Med</source><year>2015</year><volume>45</volume><issue>3</issue><fpage>365</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1007/s40279-014-0267-6</pub-id><pub-id pub-id-type="pmid">25277808</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christodoulou</surname><given-names>S</given-names></name><name><surname>Goula</surname><given-names>T</given-names></name><name><surname>Ververidis</surname><given-names>A</given-names></name><name><surname>Drosos</surname><given-names>G</given-names></name></person-group><article-title>Vitamin D and bone disease</article-title><source>Biomed Res Int</source><year>2013</year><volume>396541</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1155/2013/396541</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname><given-names>JJ</given-names></name><name><surname>Pourshahidi</surname><given-names>LK</given-names></name><name><surname>McSorley</surname><given-names>EM</given-names></name><name><surname>Madigan</surname><given-names>SM</given-names></name><name><surname>Magee</surname><given-names>PJ</given-names></name></person-group><article-title>Vitamin D: recent advances and implications for athletes</article-title><source>Sports Med</source><year>2015</year><volume>45</volume><issue>2</issue><fpage>213</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1007/s40279-014-0266-7</pub-id><pub-id pub-id-type="pmid">25252613</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>AR</given-names></name></person-group><article-title>Who, what, where and when-influences on cutaneous vitamin D synthesis</article-title><source>Prog Biophys Mol Biol</source><year>2006</year><volume>92</volume><issue>1</issue><fpage>17</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2006.02.004</pub-id><pub-id pub-id-type="pmid">16766240</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephensen</surname><given-names>CB</given-names></name><name><surname>Zerofsky</surname><given-names>M</given-names></name><name><surname>Burnett</surname><given-names>DJ</given-names></name><name><surname>Lin</surname><given-names>YP</given-names></name><name><surname>Hammock</surname><given-names>BD</given-names></name><name><surname>Hall</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Ergocalciferol from mushrooms or supplements consumed with a standard meal increases 25-hydroxyergocalciferol but decreases 25-hydroxycholecalciferol in the serum of healthy adults</article-title><source>J Nutr</source><year>2012</year><volume>142</volume><issue>7</issue><fpage>1246</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.3945/jn.112.159764</pub-id><pub-id pub-id-type="pmid">22623385</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>TC</given-names></name><name><surname>Chimeh</surname><given-names>F</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Mathieu</surname><given-names>J</given-names></name><name><surname>Person</surname><given-names>KS</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name><etal/></person-group><article-title>Factors that influence the cutaneous synthesis and dietary sources of vitamin D</article-title><source>Arch Biochem Biophys</source><year>2007</year><volume>460</volume><issue>2</issue><fpage>213</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2006.12.017</pub-id><pub-id pub-id-type="pmid">17254541</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aranow</surname><given-names>C</given-names></name></person-group><article-title>Vitamin D and the immune system</article-title><source>J Invest Med</source><year>2011</year><volume>59</volume><issue>6</issue><fpage>881</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.2310/JIM.0b013e31821b8755</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haussler</surname><given-names>M</given-names></name><name><surname>Haussler</surname><given-names>C</given-names></name><name><surname>Jurutka</surname><given-names>P</given-names></name><name><surname>Thompson</surname><given-names>P</given-names></name><name><surname>Hsieh</surname><given-names>J</given-names></name><name><surname>Remus</surname><given-names>L</given-names></name><etal/></person-group><article-title>The vitamin D hormone and its nuclear receptor: molecular actions and disease states</article-title><source>J Endocrinol</source><year>1997</year><volume>154</volume><fpage>S57</fpage><lpage>S73</lpage><pub-id pub-id-type="doi">10.1677/joe.0.1540057</pub-id><pub-id pub-id-type="pmid">9379138</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrell</surname><given-names>S</given-names></name><name><surname>Cleaver</surname><given-names>J</given-names></name><name><surname>Willis</surname><given-names>B</given-names></name></person-group><article-title>Cardiorespiratory fitness, adiposity, and serum 25-dihydroxyvitamin D levels in men</article-title><source>Med Sci Sports Exerc</source><year>2011</year><volume>43</volume><issue>2</issue><fpage>266</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e3181ed5ec6</pub-id><pub-id pub-id-type="pmid">20581717</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>J</given-names></name><name><surname>Peterson</surname><given-names>B</given-names></name><name><surname>Warpeha</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>P</given-names></name><name><surname>Rhodes</surname><given-names>G</given-names></name><name><surname>Ingraham</surname><given-names>S</given-names></name></person-group><article-title>Vitamin D status and V[combining dot above]O2peak during a skate treadmill graded exercise test in competitive ice hockey players</article-title><source>J Strength Cond Res</source><year>2014</year><volume>28</volume><issue>11</issue><fpage>3200</fpage><lpage>3205</lpage><pub-id pub-id-type="doi">10.1519/JSC.0000000000000523</pub-id><pub-id pub-id-type="pmid">24832977</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forney</surname><given-names>LA</given-names></name><name><surname>Earnest</surname><given-names>CP</given-names></name><name><surname>Henagan</surname><given-names>TM</given-names></name><name><surname>Johnson</surname><given-names>LE</given-names></name><name><surname>Castleberry</surname><given-names>TJ</given-names></name><name><surname>Stewart</surname><given-names>LK</given-names></name></person-group><article-title>Vitamin D status, body composition, and fitness measures in college-aged students</article-title><source>J Strength Cond Res</source><year>2014</year><volume>28</volume><issue>3</issue><fpage>814</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1519/JSC.0b013e3182a35ed0</pub-id><pub-id pub-id-type="pmid">23897020</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregory</surname><given-names>SM</given-names></name><name><surname>Parker</surname><given-names>BA</given-names></name><name><surname>Capizzi</surname><given-names>JA</given-names></name><name><surname>Grimaldi</surname><given-names>AS</given-names></name><name><surname>Clarkson</surname><given-names>PM</given-names></name><name><surname>Moeckel-Cole</surname><given-names>S</given-names></name><etal/></person-group><article-title>Changes in vitamin D are not associated with changes in cardiorespiratory fitness</article-title><source>Clin Med Res</source><year>2013</year><volume>2</volume><issue>4</issue><fpage>68</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.11648/j.cmr.20130204.16</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koundourakis</surname><given-names>N</given-names></name><name><surname>Androulakis</surname><given-names>N</given-names></name><name><surname>Malliaraki</surname><given-names>N</given-names></name><name><surname>Margioris</surname><given-names>A</given-names></name></person-group><article-title>Vitamin D and exercise performance in professional soccer players</article-title><source>PLoS One</source><year>2014</year><volume>1</volume><issue>7</issue><fpage>e101659</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0101659</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>JS</given-names></name><name><surname>Peterson</surname><given-names>BJ</given-names></name><name><surname>Warpeha</surname><given-names>JM</given-names></name><name><surname>Johnson</surname><given-names>SC</given-names></name><name><surname>Ingraham</surname><given-names>SJ</given-names></name></person-group><article-title>Association between Vitamin D Status and maximal-intensity exercise performance in junior and collegiate hockey players</article-title><source>J Strength Cond Res</source><year>2015</year><volume>29</volume><issue>9</issue><fpage>13</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1519/JSC.0000000000000887</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahlquist</surname><given-names>DT</given-names></name><name><surname>Dieter</surname><given-names>BP</given-names></name><name><surname>Koehle</surname><given-names>MS</given-names></name></person-group><article-title>Plausible ergogenic effects of vitamin D on athletic performance and recovery</article-title><source>J Int Soc Sports Nutr</source><year>2015</year><volume>12</volume><issue>33</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">25650043</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helgerud</surname><given-names>J</given-names></name><name><surname>Engen</surname><given-names>L</given-names></name><name><surname>Wisloff</surname><given-names>U</given-names></name><name><surname>Hoff</surname><given-names>J</given-names></name></person-group><article-title>Aerobic endurance training improves soccer performance</article-title><source>Med Sci Sports Exerc</source><year>2001</year><volume>33</volume><issue>11</issue><fpage>1925</fpage><lpage>1931</lpage><pub-id pub-id-type="doi">10.1097/00005768-200111000-00019</pub-id><pub-id pub-id-type="pmid">11689745</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassett</surname><given-names>D</given-names></name><name><surname>Howley</surname><given-names>E</given-names></name></person-group><article-title>Limiting factors for maximum oxygen uptake and determinants of endurance performance</article-title><source>Med Sci Sports Exerc</source><year>2000</year><volume>31</volume><issue>1</issue><fpage>70</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1097/00005768-200001000-00012</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Autier</surname><given-names>P</given-names></name><name><surname>Boniol</surname><given-names>M</given-names></name><name><surname>Pizot</surname><given-names>C</given-names></name><name><surname>Mullie</surname><given-names>P</given-names></name></person-group><article-title>Vitamin D status and ill health: a systematic review</article-title><source>Lancet Diabetes Endocrinol</source><year>2014</year><volume>2</volume><issue>1</issue><fpage>76</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/S2213-8587(13)70165-7</pub-id><pub-id pub-id-type="pmid">24622671</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toxqui</surname><given-names>L</given-names></name><name><surname>P&#x000e9;rez-Granados</surname><given-names>AM</given-names></name><name><surname>Blanco-Rojo</surname><given-names>R</given-names></name><name><surname>Wright</surname><given-names>I</given-names></name><name><surname>Gonz&#x000e1;lez-Vizcayno</surname><given-names>C</given-names></name><name><surname>Vaquero</surname><given-names>MP</given-names></name></person-group><article-title>Effects of an iron or iron and vitamin D-fortified flavored skim milk on iron metabolism: a randomized controlled double-blind trial in iron-deficient women</article-title><source>J Am Coll Nutr</source><year>2013</year><volume>32</volume><issue>5</issue><fpage>312</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1080/07315724.2013.826116</pub-id><pub-id pub-id-type="pmid">24219374</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacchetta</surname><given-names>J</given-names></name><name><surname>Zaritsky</surname><given-names>JJ</given-names></name><name><surname>Sea</surname><given-names>JL</given-names></name><name><surname>Chun</surname><given-names>RF</given-names></name><name><surname>Lisse</surname><given-names>TS</given-names></name><name><surname>Zavala</surname><given-names>K</given-names></name><etal/></person-group><article-title>Suppression of iron-regulatory hepcidin by vitamin D</article-title><source>J Am Soc Nephrol</source><year>2014</year><volume>25</volume><issue>3</issue><fpage>564</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1681/ASN.2013040355</pub-id><pub-id pub-id-type="pmid">24204002</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zughaier</surname><given-names>SM</given-names></name><name><surname>Alvarez</surname><given-names>JA</given-names></name><name><surname>Sloan</surname><given-names>JH</given-names></name><name><surname>Konrad</surname><given-names>RJ</given-names></name><name><surname>Tangpricha</surname><given-names>V</given-names></name></person-group><article-title>The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes</article-title><source>J Clin Transl Endocrinol</source><year>2014</year><volume>1</volume><issue>1</issue><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.jcte.2014.01.003</pub-id><pub-id pub-id-type="pmid">25097830</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemeth</surname><given-names>E</given-names></name><name><surname>Ganz</surname><given-names>T</given-names></name></person-group><article-title>Regulation of iron metabolism by hepcidin</article-title><source>Annu Rev Nutr</source><year>2006</year><volume>26</volume><fpage>323</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1146/annurev.nutr.26.061505.111303</pub-id><pub-id pub-id-type="pmid">16848710</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganz</surname><given-names>T</given-names></name><name><surname>Nemeth</surname><given-names>E</given-names></name></person-group><article-title>Hepcidin and iron homeostasis</article-title><source>Biochim Biophys Acta</source><year>2012</year><volume>1823</volume><issue>9</issue><fpage>1434</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2012.01.014</pub-id><pub-id pub-id-type="pmid">22306005</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>E</given-names></name></person-group><article-title>Hepcidin: the iron regulatory hormone</article-title><source>Clin Biochem Rev</source><year>2005</year><volume>26</volume><issue>3</issue><fpage>47</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">16450011</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghiasvand</surname><given-names>R</given-names></name><name><surname>Askari</surname><given-names>G</given-names></name><name><surname>Malekzadeh</surname><given-names>J</given-names></name><name><surname>Hajishafiee</surname><given-names>M</given-names></name><name><surname>Daneshvar</surname><given-names>P</given-names></name><name><surname>Akbari</surname><given-names>F</given-names></name><etal/></person-group><article-title>Effects of six weeks of &#x003b2;-alanine administration on VO<sub>2</sub> max, time to exhaustion and lactate concentrations in physical education students</article-title><source>Int J Prev Med</source><year>2012</year><volume>3</volume><issue>8</issue><fpage>559</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">22973486</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durkalec-Michalski</surname><given-names>K</given-names></name><name><surname>Jeszka</surname><given-names>J</given-names></name></person-group><article-title>The efficacy of a &#x003b2;-hydroxy-&#x003b2;-methylbutyrate supplementation on physical capacity, body composition and biochemical markers in elite rowers: a randomised, double-blind, placebo-controlled crossover study</article-title><source>J Int Soc Sports Nutr</source><year>2015</year><volume>12</volume><fpage>31</fpage><pub-id pub-id-type="doi">10.1186/s12970-015-0092-9</pub-id><pub-id pub-id-type="pmid">26225130</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolpern</surname><given-names>AE</given-names></name><name><surname>Burgos</surname><given-names>DJ</given-names></name><name><surname>Janot</surname><given-names>JM</given-names></name><name><surname>Dalleck</surname><given-names>LC</given-names></name></person-group><article-title>Is a threshold-based model a superior method to the relative percent concept for establishing individual exercise intensity? a randomized controlled trial</article-title><source>BMC Sports Sci Med Rehabil</source><year>2015</year><volume>7</volume><issue>16</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">25973205</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Minim: Allocation by minimisation in clinical trials [homepage on the Internet]. 14th Mar 2013. Available from: <ext-link ext-link-type="uri" xlink:href="https://www-users.york.ac.uk/%7emb55/guide/minim.htm">https://www-users.york.ac.uk/~mb55/guide/minim.htm</ext-link></mixed-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holick</surname><given-names>MF</given-names></name><name><surname>Binkley</surname><given-names>NC</given-names></name><name><surname>Bischoff-Ferrari</surname><given-names>HA</given-names></name><name><surname>Gordon</surname><given-names>CM</given-names></name><name><surname>Hanley</surname><given-names>DA</given-names></name><name><surname>Heaney</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Evaluation, treatment, and prevention of&#x000a0;vitamin D&#x000a0;deficiency: an endocrine society clinical practice guideline</article-title><source>J Clin Endocrinol Metab</source><year>2011</year><volume>96</volume><issue>7</issue><fpage>1911</fpage><lpage>1930</lpage><pub-id pub-id-type="doi">10.1210/jc.2011-0385</pub-id><pub-id pub-id-type="pmid">21646368</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannell</surname><given-names>JJ</given-names></name><name><surname>Hollis</surname><given-names>BW</given-names></name><name><surname>Zasloff</surname><given-names>M</given-names></name><name><surname>Heaney</surname><given-names>RP</given-names></name></person-group><article-title>Diagnosis and treatment of vitamin D deficiency</article-title><source>Expert Opin Pharmacother</source><year>2008</year><volume>9</volume><issue>1</issue><fpage>107</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1517/14656566.9.1.107</pub-id><pub-id pub-id-type="pmid">18076342</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bischoff-Ferrari</surname><given-names>HA</given-names></name><name><surname>Giovannucci</surname><given-names>E</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Dietrich</surname><given-names>T</given-names></name><name><surname>Dawson-Hughes</surname><given-names>B</given-names></name></person-group><article-title>Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes</article-title><source>Am J Clin Nutr</source><year>2006</year><volume>84</volume><issue>1</issue><fpage>18</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">16825677</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lips</surname><given-names>P</given-names></name></person-group><article-title>Vitamin D physiology</article-title><source>Prog Biophys Mol Biol</source><year>2006</year><volume>92</volume><issue>1</issue><fpage>4</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2006.02.016</pub-id><pub-id pub-id-type="pmid">16563471</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNeely</surname><given-names>MDD</given-names></name></person-group><article-title>The estimated glomerular filtration rate: linchpin of the chronic kidney disease guidelines</article-title><source>BCM J</source><year>2005</year><volume>2005</volume><issue>47</issue><fpage>287</fpage><lpage>291</lpage></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Badr</surname><given-names>W</given-names></name><name><surname>Martin</surname><given-names>KJ</given-names></name></person-group><article-title>Vitamin D and kidney disease</article-title><source>CJASN</source><year>2008</year><volume>3</volume><issue>5</issue><fpage>1555</fpage><lpage>1560</lpage><pub-id pub-id-type="doi">10.2215/CJN.01150308</pub-id><pub-id pub-id-type="pmid">18450926</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>LA</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Feldman</surname><given-names>HI</given-names></name><name><surname>Greene</surname><given-names>T</given-names></name><name><surname>Lash</surname><given-names>JP</given-names></name><name><surname>Nelson</surname><given-names>RG</given-names></name><etal/></person-group><article-title>Evaluation of the modification of diet in renal disease study equation in a large diverse population</article-title><source>J Am Soc Nephrol</source><year>2007</year><volume>18</volume><issue>10</issue><fpage>2749</fpage><lpage>2757</lpage><pub-id pub-id-type="doi">10.1681/ASN.2007020199</pub-id><pub-id pub-id-type="pmid">17855641</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trampisch</surname><given-names>US</given-names></name><name><surname>Franke</surname><given-names>J</given-names></name><name><surname>Jedamzik</surname><given-names>N</given-names></name><name><surname>Hinrichs</surname><given-names>T</given-names></name><name><surname>Platen</surname><given-names>P</given-names></name></person-group><article-title>Optimal Jamar dynamometer handle position to assess maximal isometric hand grip strength in epidemiological studies</article-title><source>J Hand Surg</source><year>2012</year><volume>37</volume><issue>11</issue><fpage>2368</fpage><lpage>2373</lpage><pub-id pub-id-type="doi">10.1016/j.jhsa.2012.08.014</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linthorne</surname><given-names>N</given-names></name></person-group><article-title>Analysis of standing vertical jumps using a force platform</article-title><source>Am J Phys</source><year>2001</year><volume>69</volume><issue>11</issue><fpage>1198</fpage><lpage>1204</lpage><pub-id pub-id-type="doi">10.1119/1.1397460</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>T</given-names></name><name><surname>Georg</surname><given-names>T</given-names></name><name><surname>Becker</surname><given-names>C</given-names></name><name><surname>Kindermann</surname><given-names>W</given-names></name></person-group><article-title>Reliability of gas exchange measurements from two different spiroergometry systems</article-title><source>Int J Sports Med</source><year>2001</year><volume>22</volume><issue>8</issue><fpage>593</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1055/s-2001-18523</pub-id><pub-id pub-id-type="pmid">11719895</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Monahan</surname><given-names>KD</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Age-predicted maximal heart rate revisited</article-title><source>J Am Coll Cardiol</source><year>2001</year><volume>37</volume><issue>1</issue><fpage>153</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(00)01054-8</pub-id><pub-id pub-id-type="pmid">11153730</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodwin</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>J</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>A</given-names></name><name><surname>Gladden</surname><given-names>L</given-names></name></person-group><article-title>Blood lactate measurements and analysis during exercise: a guide for clinicians</article-title><source>J Diabetes Sci Technol</source><year>2007</year><volume>1</volume><issue>4</issue><fpage>558</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1177/193229680700100414</pub-id><pub-id pub-id-type="pmid">19885119</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edvardsen</surname><given-names>E</given-names></name><name><surname>Hem</surname><given-names>E</given-names></name><name><surname>Anderssen</surname><given-names>SA</given-names></name></person-group><article-title>End criteria for reaching maximal oxygen uptake must be strict and adjusted to sex and age: a cross-sectional study</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>1</issue><fpage>e85276</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0085276</pub-id><pub-id pub-id-type="pmid">24454832</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fields</surname><given-names>DA</given-names></name><name><surname>Goran</surname><given-names>MI</given-names></name><name><surname>McCrory</surname><given-names>MA</given-names></name></person-group><article-title>Body-composition assessment via air-displacement plethysmography in adults and children: a review</article-title><source>Am J Clin Nutr</source><year>2002</year><volume>75</volume><issue>3</issue><fpage>453</fpage><lpage>467</lpage><pub-id pub-id-type="pmid">11864850</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Siri</surname><given-names>W</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Brozek</surname><given-names>J</given-names></name><name><surname>Henschel</surname><given-names>A</given-names></name></person-group><article-title>Body composition from fluid spaces and density: analysis of methods</article-title><source>Techniques for measuring body composition</source><year>1961</year><publisher-loc>Washington</publisher-loc><publisher-name>National Academy of Sciences</publisher-name><fpage>223</fpage><lpage>244</lpage></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>TJ</given-names></name><name><surname>Fewtrell</surname><given-names>MS</given-names></name><name><surname>Prentice</surname><given-names>A</given-names></name></person-group><article-title>The fallacy of using percentage body fat as a measure of adiposity</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>87</volume><issue>6</issue><fpage>1959</fpage><lpage>1960</lpage><pub-id pub-id-type="pmid">18541591</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weir</surname><given-names>RR</given-names></name><name><surname>Carson</surname><given-names>EL</given-names></name><name><surname>Mulhern</surname><given-names>MS</given-names></name><name><surname>Laird</surname><given-names>E</given-names></name><name><surname>Healy</surname><given-names>M</given-names></name><name><surname>Pourshahidi</surname><given-names>LK</given-names></name></person-group><article-title>Validation of a food frequency questionnaire to determine vitamin D intakes using the method of triads</article-title><source>J Hum Nutr Diet</source><year>2015</year><volume>29</volume><issue>2</issue><fpage>255</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1111/jhn.12328</pub-id><pub-id pub-id-type="pmid">26249157</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiro</surname><given-names>A</given-names></name><name><surname>Buttriss</surname><given-names>J</given-names></name></person-group><article-title>Vitamin D: an overview of vitamin D status and intake in Europe</article-title><source>Nutr Bull</source><year>2014</year><volume>39</volume><issue>4</issue><fpage>322</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1111/nbu.12108</pub-id><pub-id pub-id-type="pmid">25635171</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvo</surname><given-names>MS</given-names></name><name><surname>Whiting</surname><given-names>SJ</given-names></name><name><surname>Barton</surname><given-names>CN</given-names></name></person-group><article-title>Vitamin D intake: a global perspective of current status</article-title><source>J Nutr</source><year>2005</year><volume>135</volume><fpage>310</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">15671233</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>M</given-names></name><name><surname>Atkinson</surname><given-names>M</given-names></name><name><surname>Meyer</surname><given-names>J</given-names></name></person-group><source>A photographic atlas of food portion sizes</source><year>1997</year><publisher-loc>London</publisher-loc><publisher-name>MAFF Publications</publisher-name></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besson</surname><given-names>H</given-names></name><name><surname>Brage</surname><given-names>S</given-names></name><name><surname>Jakes</surname><given-names>R</given-names></name><name><surname>Ekelund</surname><given-names>U</given-names></name><name><surname>Wareham</surname><given-names>N</given-names></name></person-group><article-title>Estimating physical activity energy expenditure, sedentary time, and physical activity intensity by self-report in adults</article-title><source>Am J Clin Nutr</source><year>2010</year><volume>91</volume><issue>1</issue><fpage>106</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.3945/ajcn.2009.28432</pub-id><pub-id pub-id-type="pmid">19889820</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="other">Cregg CJ, Kelly D, O&#x02019;Connor PL, Daly P, Moyna NM (2013) In: Effects of high intensity interval training and high volume endurance training on maximal aerobic capacity, speed and power in club-level Gaelic football players. May 28&#x02013;June 1; Indianapolis, Indiana. American College of Sports Medicine 60th annual meeting and 4th world congress on exercise is medicine</mixed-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Hopewell</surname><given-names>S</given-names></name><name><surname>Schulz</surname><given-names>KF</given-names></name><name><surname>Montori</surname><given-names>V</given-names></name><name><surname>G&#x000f8;tzsche</surname><given-names>PC</given-names></name><name><surname>Devereaux</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials</article-title><source>BMJ</source><year>2010</year><volume>340</volume><fpage>C869</fpage><pub-id pub-id-type="doi">10.1136/bmj.c869</pub-id><pub-id pub-id-type="pmid">20332511</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>JW</given-names></name><name><surname>Olchowski</surname><given-names>AE</given-names></name></person-group><article-title>Gilreath TD (2007) How many imputations are really needed? some practical clarifications of multiple imputation theory</article-title><source>Prev Sci</source><year>2007</year><volume>8</volume><fpage>206</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1007/s11121-007-0070-9</pub-id><pub-id pub-id-type="pmid">17549635</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahan</surname><given-names>B</given-names></name><name><surname>Jairath</surname><given-names>V</given-names></name><name><surname>Dor&#x000e9;</surname><given-names>C</given-names></name><name><surname>Morris</surname><given-names>T</given-names></name></person-group><article-title>The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies</article-title><source>Trials</source><year>2014</year><volume>15</volume><fpage>139</fpage><pub-id pub-id-type="doi">10.1186/1745-6215-15-139</pub-id><pub-id pub-id-type="pmid">24755011</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goran</surname><given-names>M</given-names></name><name><surname>Fields</surname><given-names>DA</given-names></name><name><surname>Hunter</surname><given-names>GR</given-names></name><name><surname>Herd</surname><given-names>SL</given-names></name><name><surname>Weinsier</surname><given-names>RL</given-names></name></person-group><article-title>Total body fat does not influence maximal aerobic capacity</article-title><source>Int J Obes Relat Metab Disord</source><year>2000</year><volume>24</volume><issue>7</issue><fpage>841</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1038/sj.ijo.0801241</pub-id><pub-id pub-id-type="pmid">10918530</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>RL</given-names></name><name><surname>Nzekwu</surname><given-names>MM</given-names></name></person-group><article-title>The effects of body mass index on lung volumes</article-title><source>Chest</source><year>2006</year><volume>130</volume><issue>3</issue><fpage>827</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1378/chest.130.3.827</pub-id><pub-id pub-id-type="pmid">16963682</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gormley</surname><given-names>SE</given-names></name><name><surname>Swain</surname><given-names>DP</given-names></name><name><surname>High</surname><given-names>R</given-names></name><name><surname>Spina</surname><given-names>RJ</given-names></name><name><surname>Dowling</surname><given-names>EA</given-names></name><name><surname>Kotipalli</surname><given-names>US</given-names></name><etal/></person-group><article-title>Effect of intensity of aerobic training on VO<sub>2</sub> max</article-title><source>Med Sci Sports Exerc</source><year>2008</year><volume>40</volume><issue>7</issue><fpage>1336</fpage><lpage>1343</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e31816c4839</pub-id><pub-id pub-id-type="pmid">18580415</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruton</surname><given-names>A</given-names></name><name><surname>Conway</surname><given-names>JH</given-names></name><name><surname>Holgate</surname><given-names>ST</given-names></name></person-group><article-title>Reliability: what is it, and how is it measured?</article-title><source>Physiotherapy</source><year>2000</year><volume>86</volume><issue>2</issue><fpage>94</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/S0031-9406(05)61211-4</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tighe</surname><given-names>J</given-names></name><name><surname>McManus</surname><given-names>IC</given-names></name><name><surname>Dewhurst</surname><given-names>NG</given-names></name><name><surname>Chis</surname><given-names>L</given-names></name><name><surname>Mucklow</surname><given-names>J</given-names></name></person-group><article-title>The standard error of measurement is a more appropriate measure of quality for postgraduate medical assessments than is reliability: an analysis of MRCP(UK) examinations</article-title><source>BMC Med Educ</source><year>2010</year><volume>10</volume><issue>40</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20074350</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laird</surname><given-names>E</given-names></name><name><surname>Ward</surname><given-names>M</given-names></name><name><surname>McSorley</surname><given-names>E</given-names></name><name><surname>Strain</surname><given-names>JJ</given-names></name><name><surname>Wallace</surname><given-names>J</given-names></name></person-group><article-title>Vitamin D&#x000a0;and bone health: potential mechanisms</article-title><source>Nutrients</source><year>2010</year><volume>2</volume><issue>7</issue><fpage>693</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.3390/nu2070693</pub-id><pub-id pub-id-type="pmid">22254049</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holick</surname><given-names>MF</given-names></name></person-group><article-title>Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease</article-title><source>Am J Clin Nutr</source><year>2004</year><volume>80</volume><issue>6S</issue><fpage>1678</fpage><lpage>1688</lpage></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thacher</surname><given-names>TD</given-names></name><name><surname>Clarke</surname><given-names>BL</given-names></name></person-group><article-title>Vitamin D insufficiency</article-title><source>Mayo Clin Proc</source><year>2011</year><volume>86</volume><issue>1</issue><fpage>50</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.4065/mcp.2010.0567</pub-id><pub-id pub-id-type="pmid">21193656</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storlie</surname><given-names>DM</given-names></name><name><surname>Pritchett</surname><given-names>K</given-names></name><name><surname>Pritchett</surname><given-names>R</given-names></name><name><surname>Cashman</surname><given-names>C</given-names></name></person-group><article-title>12-week vitamin D supplementation trial does not significantly influence seasonal 25(OH)D status in male collegiate athletes</article-title><source>Int J Health Nutr</source><year>2011</year><volume>2</volume><issue>2</issue><fpage>8</fpage><lpage>13</lpage></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Close</surname><given-names>GL</given-names></name><name><surname>Fraser</surname><given-names>WD</given-names></name></person-group><article-title>Vitamin D supplementation for athletes: too much of a good thing?</article-title><source>Sport Exerc Sci</source><year>2012</year><volume>33</volume><fpage>24</fpage><lpage>25</lpage></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heaney</surname><given-names>RP</given-names></name></person-group><article-title>Assessing vitamin D status</article-title><source>Curr Opin Clin Nutr Metab Care</source><year>2011</year><volume>14</volume><issue>5</issue><fpage>440</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1097/MCO.0b013e328348ed85</pub-id><pub-id pub-id-type="pmid">21832900</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>G</given-names></name></person-group><article-title>Pharmacokinetics of vitamin D toxicity</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>88</volume><issue>2</issue><fpage>582S</fpage><lpage>586S</lpage><pub-id pub-id-type="pmid">18689406</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverberg</surname><given-names>SJ</given-names></name></person-group><article-title>Vitamin D deficiency and primary hyperparathyroidism</article-title><source>J Bone Miner Res</source><year>2007</year><volume>22</volume><issue>S2</issue><fpage>100</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1359/jbmr.07s202</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aadahl</surname><given-names>M</given-names></name><name><surname>Kjaer</surname><given-names>M</given-names></name><name><surname>Kristensen</surname><given-names>JH</given-names></name><name><surname>Mollerup</surname><given-names>B</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>T</given-names></name></person-group><article-title>Self-reported physical activity compared with maximal oxygen uptake in adults</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2007</year><volume>14</volume><issue>3</issue><fpage>422</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1097/HJR.0b013e3280128d00</pub-id><pub-id pub-id-type="pmid">17568243</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrell</surname><given-names>SW</given-names></name><name><surname>Willis</surname><given-names>BL</given-names></name><name><surname>Willis</surname><given-names>B</given-names></name></person-group><article-title>Cardiorespiratory fitness, adiposity, and serum 25-dihydroxyvitamin D levels in women: the cooper center longitudinal study</article-title><source>J Womens Health (Larchmt)</source><year>2012</year><volume>21</volume><issue>1</issue><fpage>80</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1089/jwh.2010.2684</pub-id><pub-id pub-id-type="pmid">21970522</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mowry</surname><given-names>DA</given-names></name><name><surname>Costello</surname><given-names>MM</given-names></name><name><surname>Heelan</surname><given-names>KA</given-names></name></person-group><article-title>Association among cardiorespiratory fitness, body fat, and bone marker measurements in healthy young females</article-title><source>J Am Osteopath Assoc</source><year>2009</year><volume>109</volume><issue>10</issue><fpage>534</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">19861594</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valtue&#x000f1;a</surname><given-names>J</given-names></name><name><surname>Gracia-Marco</surname><given-names>L</given-names></name><name><surname>Huybrechts</surname><given-names>I</given-names></name><name><surname>Breidenassel</surname><given-names>C</given-names></name><name><surname>Ferrari</surname><given-names>M</given-names></name><name><surname>Gottrand</surname><given-names>F</given-names></name><etal/></person-group><article-title>Cardiorespiratory fitness in males, and upper limbs muscular strength in females, are positively related with 25-hydroxyvitamin D plasma concentrations in European adolescents: the HELENA study</article-title><source>QJM</source><year>2013</year><volume>106</volume><issue>9</issue><fpage>809</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1093/qjmed/hct089</pub-id><pub-id pub-id-type="pmid">23657707</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jastrz&#x00119;bski</surname><given-names>Z</given-names></name></person-group><article-title>Effect of vitamin D supplementation on the level of physical fitness and blood parameters of rowers during the 8-week high intensity training</article-title><source>Facicula Educa&#x00163;ie Fizic&#x00103; &#x0015f;i Sport</source><year>2015</year><volume>2</volume><fpage>57</fpage><lpage>67</lpage></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scholten</surname><given-names>SD</given-names></name><name><surname>Sergeev</surname><given-names>IN</given-names></name><name><surname>Song</surname><given-names>Q</given-names></name><name><surname>Birger</surname><given-names>CB</given-names></name></person-group><article-title>Effects of vitamin D and quercetin, alone and in combination, on cardiorespiratory fitness and muscle function in physically active male adults</article-title><source>Open Access J Sports Med</source><year>2015</year><volume>24</volume><issue>6</issue><fpage>229</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.2147/OAJSM.S83159</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boxer</surname><given-names>RS</given-names></name><name><surname>Kenny</surname><given-names>AM</given-names></name><name><surname>Schmotzer</surname><given-names>BJ</given-names></name><name><surname>Vest</surname><given-names>M</given-names></name><name><surname>Fiutem</surname><given-names>JJ</given-names></name><name><surname>Pi&#x000f1;a</surname><given-names>IL</given-names></name></person-group><article-title>A randomized controlled trial of high dose vitamin D<sub>3</sub> in patients with heart failure</article-title><source>JACC Heart Fail</source><year>2013</year><volume>1</volume><issue>1</issue><fpage>84</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.jchf.2012.11.003</pub-id><pub-id pub-id-type="pmid">24614995</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornikx</surname><given-names>M</given-names></name><name><surname>Van Remoortel</surname><given-names>H</given-names></name><name><surname>Lehouck</surname><given-names>A</given-names></name><name><surname>Mathieu</surname><given-names>C</given-names></name><name><surname>Maes</surname><given-names>K</given-names></name><name><surname>Gayan-Ramirez</surname><given-names>G</given-names></name><etal/></person-group><article-title>Vitamin D supplementation during rehabilitation in COPD: a secondary analysis of a randomized trial</article-title><source>Respir Res</source><year>2012</year><volume>13</volume><issue>84</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22214516</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blomqvist</surname><given-names>CG</given-names></name><name><surname>Saltin</surname><given-names>B</given-names></name></person-group><article-title>Cardiovascular adaptations to physical training</article-title><source>Annu Rev Physiol</source><year>1983</year><volume>45</volume><fpage>169</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1146/annurev.ph.45.030183.001125</pub-id><pub-id pub-id-type="pmid">6221687</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girgis</surname><given-names>CM</given-names></name><name><surname>Clifton-Bligh</surname><given-names>RJ</given-names></name><name><surname>Hamrick</surname><given-names>MW</given-names></name><name><surname>Holick</surname><given-names>MF</given-names></name><name><surname>Gunton</surname><given-names>JE</given-names></name></person-group><article-title>The roles of vitamin D in skeletal muscle: form, function, and metabolism</article-title><source>Endocr Rev</source><year>2013</year><volume>34</volume><issue>1</issue><fpage>33</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1210/er.2012-1012</pub-id><pub-id pub-id-type="pmid">23169676</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Close</surname><given-names>GL</given-names></name><name><surname>Leckey</surname><given-names>J</given-names></name><name><surname>Patterson</surname><given-names>M</given-names></name><name><surname>Bradley</surname><given-names>W</given-names></name><name><surname>Owens</surname><given-names>DJ</given-names></name><name><surname>Fraser</surname><given-names>WD</given-names></name><etal/></person-group><article-title>The effects of vitamin D(3) supplementation on serum total 25[OH]D concentration and physical performance: a randomised dose-response study</article-title><source>Br J Sports Med</source><year>2013</year><volume>47</volume><issue>11</issue><fpage>692</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2012-091735</pub-id><pub-id pub-id-type="pmid">23410885</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Close</surname><given-names>GL</given-names></name><name><surname>Russell</surname><given-names>J</given-names></name><name><surname>Cobley</surname><given-names>JN</given-names></name><name><surname>Owens</surname><given-names>DJ</given-names></name><name><surname>Wilson</surname><given-names>G</given-names></name><name><surname>Gregson</surname><given-names>W</given-names></name><etal/></person-group><article-title>Assessment of vitamin D concentration in non-supplemented professional athletes and healthy adults during the winter months in the UK: implications for skeletal muscle function</article-title><source>J Sports Sci</source><year>2013</year><volume>31</volume><issue>4</issue><fpage>344</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1080/02640414.2012.733822</pub-id><pub-id pub-id-type="pmid">23083379</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubnov-Raz</surname><given-names>G</given-names></name><name><surname>Livne</surname><given-names>N</given-names></name><name><surname>Raz</surname><given-names>R</given-names></name><name><surname>Cohen</surname><given-names>AH</given-names></name><name><surname>Constantini</surname><given-names>NW</given-names></name></person-group><article-title>Vitamin D Supplementation and physical performance in adolescent swimmers</article-title><source>Int J Sport Nutr Exerc Metab</source><year>2015</year><volume>25</volume><issue>4</issue><fpage>317</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1123/ijsnem.2014-0180</pub-id><pub-id pub-id-type="pmid">25203157</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bischoff</surname><given-names>HA</given-names></name><name><surname>St&#x000e4;helin</surname><given-names>HB</given-names></name><name><surname>Dick</surname><given-names>W</given-names></name><name><surname>Akos</surname><given-names>R</given-names></name><name><surname>Knecht</surname><given-names>M</given-names></name><name><surname>Salis</surname><given-names>C</given-names></name><etal/></person-group><article-title>Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial</article-title><source>J Bone Miner Res</source><year>2003</year><volume>18</volume><issue>2</issue><fpage>343</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1359/jbmr.2003.18.2.343</pub-id><pub-id pub-id-type="pmid">12568412</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeifer</surname><given-names>M</given-names></name><name><surname>Begerow</surname><given-names>B</given-names></name><name><surname>Minne</surname><given-names>HW</given-names></name><name><surname>Suppan</surname><given-names>K</given-names></name><name><surname>Fahrleitner-Pammer</surname><given-names>A</given-names></name><name><surname>Dobnig</surname><given-names>H</given-names></name></person-group><article-title>Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals</article-title><source>Osteoporos Int</source><year>2009</year><volume>20</volume><issue>2</issue><fpage>315</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1007/s00198-008-0662-7</pub-id><pub-id pub-id-type="pmid">18629569</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houston</surname><given-names>DK</given-names></name><name><surname>Tooze</surname><given-names>JA</given-names></name><name><surname>Demons</surname><given-names>JL</given-names></name><name><surname>Davis</surname><given-names>BL</given-names></name><name><surname>Shertzer-Skinner</surname><given-names>R</given-names></name><name><surname>Kearsley</surname><given-names>LB</given-names></name><etal/></person-group><article-title>Delivery of a Vitamin D intervention in homebound older adults using a meals-on-wheels program: a pilot study</article-title><source>J Am Geriatr Soc</source><year>2015</year><volume>63</volume><issue>9</issue><fpage>1861</fpage><lpage>1867</lpage><pub-id pub-id-type="doi">10.1111/jgs.13610</pub-id><pub-id pub-id-type="pmid">26277680</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>PN</given-names></name><name><surname>Scragg</surname><given-names>R</given-names></name></person-group><article-title>Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey</article-title><source>Chest</source><year>2005</year><volume>128</volume><issue>6</issue><fpage>3792</fpage><lpage>3798</lpage><pub-id pub-id-type="doi">10.1378/chest.128.6.3792</pub-id><pub-id pub-id-type="pmid">16354847</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Peng</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Lian</surname><given-names>F</given-names></name><etal/></person-group><article-title>Vitamin D deficiency is associated with decreased lung function in Chinese adults with asthma</article-title><source>Respiration</source><year>2011</year><volume>81</volume><issue>6</issue><fpage>469</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1159/000322008</pub-id><pub-id pub-id-type="pmid">21124013</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Kim</surname><given-names>HY</given-names></name><name><surname>Oh</surname><given-names>YM</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Relationship of vitamin D status with lung function and exercise capacity in COPD</article-title><source>Respirology</source><year>2015</year><volume>20</volume><issue>5</issue><fpage>782</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1111/resp.12538</pub-id><pub-id pub-id-type="pmid">25868752</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>DA</given-names></name><name><surname>Norton</surname><given-names>R</given-names></name></person-group><article-title>Vitamin D and respiratory health</article-title><source>Clin Exp Immunol</source><year>2009</year><volume>158</volume><issue>1</issue><fpage>20</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.2009.04001.x</pub-id><pub-id pub-id-type="pmid">19737226</pub-id></element-citation></ref></ref-list></back></article>